Nephrology clinical trials recruiting in Illinois

35 recruiting nephrology trials match in Illinois. Showing 20.

• Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.Recruiting

  N/A · University of Illinois at Chicago · Chicago, Illinois

• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting

  Phase 3 · Boehringer Ingelheim · Indianapolis, Indiana

• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney TransplantRecruiting

  N/A · Regeneron Pharmaceuticals · Chicago, Illinois

• Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)Recruiting

  N/A · Bodyport Inc. · Chicago, Illinois

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting

  Phase 3 · AstraZeneca · Champaign, Illinois

• Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseaseRecruiting

  Phase 1 / Phase 2 · Northwestern University · Chicago, Illinois

• Interactive Computer-adaptive Chronic Kidney Disease Education ProgramRecruiting

  N/A · University of Chicago · Chicago, Illinois

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRecruiting

  Phase 2 · Novo Nordisk A/S · Ibaraki

• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.Recruiting

  Phase 2 · AstraZeneca · Champaign, Illinois

• Study of BHV-1400 in IgA NephropathyRecruiting

  Phase 1 · Biohaven Therapeutics Ltd. · Hinsdale, Illinois

• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRDRecruiting

  Phase 1 / Phase 2 · United Therapeutics · Chicago, Illinois

• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ DonorsRecruiting

  N/A · Johns Hopkins University · Baltimore, Maryland

• Study of WAL0921 in Patients With Glomerular Kidney DiseasesRecruiting

  Phase 2 · Walden Biosciences · Hinsdale, Illinois

• Empagliflozin Treatment in Kidney Transplant RecipientsRecruiting

  Phase 4 · VA Office of Research and Development · Hines, Illinois

• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesRecruiting

  Phase 4 · Brigham and Women's Hospital · Chicago, Illinois

• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseRecruiting

  Phase 3 · Alessandro Doria · Chicago, Illinois

• Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSeaseRecruiting

  Early Phase 1 · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois

• Transformative Research in Diabetic NephropathyRecruiting

  N/A · University of Pennsylvania · Chicago, Illinois

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Recruiting

  Phase 3 · Boehringer Ingelheim · Chicago, Illinois

• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Recruiting

  Phase 2 · Akebia Therapeutics · Chula Vista, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.